INTRODUCTION
Periodontal diseases is a common infection which involves the periodontium. The periodontium are the tissues surrounding the tooth. Cardiovascular diseases on the other hand is a condition that involves the narrowing of blocked blood vessels that can lead to a series of conditions such as cardiac arrest, angina or stroke due to age, hypertension, diabetics, obesity, serum lipid concentration and abnormal habits. Periodontal diseases have been associated with cardiovascular diseases. [1]
Based on researches, for the past three decades, increasing cardiovascular diseases has been sought out due to the impact of oral hygiene. [2] Cardiovascular diseases is the leading cause of death throughout the nations of the world and the main
…show more content…
It is important for all health professionals to assess oral inflammation as a risk factor for cardiovascular disease and to activate the dental team as part of the patient care plan. [8] Because chronic systemic inflammation plays an important role in the pathogenesis of atherosclerosis, and because periodontitis has been shown to contribute to the overall level of systemic inflammation, there have been increasing calls for early interventions that would eliminate oral inflammation and reduce the overall systemic inflammatory burden. [9] Thisinterprofessional approach will have the twofold benefit of establishing more comprehensive individual risk reduction strategies and improving overall public health outcomes. [10] A limited clinical inspection is performed to identify possible signs of oral or systemic disease, malformation, or injury, and the potential need for referral for diagnosis and treatment. …show more content…
[23] While abnormal growth of the periodontal tissue is mainly associated with plaque related inflammation, drugs such as nifedipine and amlodipine, have been implicated in causing gingival overgrowth, which may be brought to dental attention because of pain, bleeding or appearance. [24]The anti-dysrhythmicagentsdisopyramide and propafenone and the anti-hypertensive drugs indoramin and methyldopa may cause a dry mouth. [15] ACE inhibitors and amiodarone sometimes give rise to altered taste, typically described as 'metallic '. If an offending drug can be identified, it may be possible (in consultation with the prescriber) to discontinue it or give an alternative.